Sientra (NASDAQ:SIEN) Third Quarter 2023 Results

Key Financial Results

• Revenue: US$19.5m (down 13% from 3Q 2022).
• Net loss: US$14.8m (flat on 3Q 2022).
• US$1.31 loss per share (improved from US$2.37 loss in 3Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sientra Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 7.0%. Earnings per share (EPS) also missed analyst estimates by 50%.

Looking ahead, revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are up 33% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Sientra has 6 warning signs (and 3 which don't sit too well with us) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.